Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS
about
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expressionA reflection on HIV/AIDS research after 25 yearsOrigins of HIV and the AIDS pandemicIdentification of functional microRNAs released through asymmetrical processing of HIV-1 TAR elementRecognition of 5'-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2.Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive tat and gp160 proteinsThe Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroRole of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA virusesStructural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysisInhibition of human immunodeficiency virus syncytium formation and virus replication by castanosperminePathogenesis of human immunodeficiency virus infectionIdentification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virionsRole of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeatBiosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transportGene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vectorSulfation of the human immunodeficiency virus envelope glycoproteinRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsTwo orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infectionConstruction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genesThe basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assemblyDarunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIVDirect inactivation of human immunodeficiency virus type 1 by a novel small-molecule entry inhibitor, DCM205Transmission of human hepatitis C virus from patients in secondary cells for long term culturePhosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcriptionTranscription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivityAnimal models in HIV cure researchNonhuman primate models for HIV/AIDS vaccine developmentHIV-1 neutralizing antibodies: understanding nature's pathwaysAnti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infectionImmunopathological study of spleen during Japanese encephalitis virus infection in miceCytopathic Mechanisms of HIV-1Causation and disease: effect of technology on postulates of causationGBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapyStructural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120Catalytic Water Co-Existing with a Product Peptide in the Active Site of HIV-1 Protease Revealed by X-Ray Structure AnalysisStructure-Based Design, Synthesis, and Characterization of Dual Hotspot Small-Molecule HIV-1 Entry InhibitorsStructural Basis of Why Nelfinavir-Resistant D30N Mutant of HIV-1 Protease Remains Susceptible to SaquinavirStructure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
P2860
Q21245193-20F373B3-74EC-45BA-ABCC-80BB6D3E9617Q21245200-1C482938-2155-4BD7-9C0B-CEFC1985ED27Q22242661-F804BB9F-C6EB-4D9A-A92C-114279A12E8DQ22242847-A0ADE3F3-D53E-41C3-BA58-557FBE0B51FEQ24515333-DF550173-4B08-4EBB-9CAE-60C72DB9B577Q24517026-15BAE13A-B1A5-46DE-976D-C98530E54C48Q24561727-ED0C68CA-2E8D-4D12-8F03-2431ABFC7D1CQ24609215-DB6784F0-215D-4D30-BB57-4B8EB3B5AFA6Q24609814-AD668D0F-A465-468A-891F-2F00CF6D500EQ24627466-6BC565B9-C6BC-4056-9743-1E708ABB3A74Q24630462-32A8C42B-FD84-4F42-929A-AB829A9C08DFQ24633025-9D51E473-062F-4804-88FF-8CD9C176F211Q24634681-90FACE8D-AA32-4744-820F-B245BF15AECEQ24645417-EA675ADE-E125-4511-9BE0-BC5C7D1E172EQ24645992-EA93C072-9FA2-4384-AA53-B1B7E40720E9Q24646043-2BB175C4-5526-4D9A-B22D-527D6CED7487Q24647777-62C50AA3-0BEA-4C82-8C21-CBD9D234D892Q24647955-9F3788A2-BF39-41AC-A5EC-C26CCD1E1B7AQ24651506-599EE24A-39A7-49B2-AE47-406D454B9713Q24652969-0E8B5A8C-4A72-4B36-9357-A33CCD0999F8Q24655892-9C916858-D832-4EA8-8522-1D292EBE19A4Q24656044-C69E11D5-5430-4387-AD78-23F1A4773D65Q24681002-5E558A7E-4603-4A3D-B1AD-B8AA6B87C131Q24681004-F7DDFC07-F7A2-4226-919C-7FFE87EDF6E1Q24800686-1D1FCAAB-9B7B-442B-A631-BC26896DBF65Q24806541-64844FE2-31F9-43DC-B430-F4E24B8A7CD9Q24815940-229AE72B-6E5D-47BA-A874-FF28EA3A6751Q26853069-8EF66997-F45B-45F1-ADFC-128BB22A9141Q26861148-5168989F-C3A0-4C17-B01D-7E28F9B0FC14Q27000480-763689E4-F5EE-4476-9EF0-61AFF74FDE04Q27473545-E999820F-354D-4EA2-A313-C3787FE1E2A8Q27481273-48557F7A-FAFB-4E93-9FC5-30760485112CQ27485043-B5038886-C4BC-473B-AF30-8D7FDAD6B168Q27487371-AD9C867A-1883-45F1-BC57-E162913C2F48Q27489561-FD77105B-056A-42E3-8EB9-AFC1331E5FF9Q27643185-A046B329-ABBE-48ED-B23D-A0C4F4A5F667Q27658259-86EB95D1-E08D-4F0A-AC2F-13C8CC0CBDAAQ27678493-6C1F6843-EBEA-4F8F-B926-8928CB7F0872Q27696689-ECE4CF2B-A52E-4737-A9F5-C0F53245D11FQ27759364-D5F5009E-4C3D-4B91-9BC4-5057B17E5B9E
P2860
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS
description
1984 nî lūn-bûn
@nan
1984 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Frequent detection and isolati ...... with AIDS and at risk for AIDS
@ast
Frequent detection and isolati ...... with AIDS and at risk for AIDS
@en
type
label
Frequent detection and isolati ...... with AIDS and at risk for AIDS
@ast
Frequent detection and isolati ...... with AIDS and at risk for AIDS
@en
prefLabel
Frequent detection and isolati ...... with AIDS and at risk for AIDS
@ast
Frequent detection and isolati ...... with AIDS and at risk for AIDS
@en
P2093
P3181
P356
P1433
P1476
Frequent detection and isolati ...... with AIDS and at risk for AIDS
@en
P2093
Redfield R
Salahuddin SZ
Shearer GM
P3181
P356
10.1126/SCIENCE.6200936
P407
P577
1984-05-04T00:00:00Z